| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/25/2001 | EP1117778A2 Methods and compositions for inducing differentiation and apoptosis in cells that overexpress the notch protein |
| 07/25/2001 | EP1117774A1 Method for generating diversity |
| 07/25/2001 | EP1117692A1 Tie2 agonist antibodies |
| 07/25/2001 | EP1117682A1 Novel peptides |
| 07/25/2001 | EP1117680A2 Ncam binding compounds |
| 07/25/2001 | EP1117675A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 07/25/2001 | EP1117672A1 Antisense modulation of survivin expression |
| 07/25/2001 | EP1117439A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 07/25/2001 | EP1117438A1 Tie2 antagonist antibodies |
| 07/25/2001 | EP1117435A1 Mutant cholera holotoxin as an adjuvant |
| 07/25/2001 | EP1117419A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 07/25/2001 | EP0577605B1 G protein-coupled glutamate receptors |
| 07/25/2001 | CN1305589A Improved immunodiagnostic assays using reducing agents |
| 07/25/2001 | CN1305531A Expression vector for use in one-step purification protocal |
| 07/25/2001 | CN1305527A Vasculogenesis correlation molecule |
| 07/25/2001 | CN1305526A Gene coding for heliomicine and use thereof |
| 07/25/2001 | CN1305497A Monoclonal antibodies directed against the G3BP protein and use |
| 07/25/2001 | CN1305003A Gene engineering process for preparing died/tried fusion protein of erythrocyte growth factor with improved bioactivity |
| 07/24/2001 | US6265567 Isolated FrpB nucleic acid molecule |
| 07/24/2001 | US6265564 Expressed ligand-vascular intercellular signalling molecule |
| 07/24/2001 | US6265563 Nucleotide sequences probes for use as diagnostic tools and drug screening |
| 07/24/2001 | US6265550 Antibody; for use in the diagnosis, prevention, and treatment of cancer, inflammation, and insulin response defects |
| 07/24/2001 | US6265548 Preferential protein for use as a tool in genetic engineering |
| 07/24/2001 | US6265547 Polypeptide for use in diagnosis, treatment, and prevention of cancer, nervous system disorders |
| 07/24/2001 | US6265545 Reading frame independent epitope tagging |
| 07/24/2001 | US6265544 Adipocyte-specific protein homologs |
| 07/24/2001 | US6265543 Polypeptide for the treatment of eye disorders, tumors, cancer, psoriasis, trauma, psychological, burns and ulcers |
| 07/24/2001 | US6265200 HIV-3 retrovirus and its use |
| 07/24/2001 | US6265196 Preparing delivery vehicle containing nuclease having a dna binding domain or gene encoding the nuclease, delivering into cells, then deactivating target |
| 07/24/2001 | US6265195 Nucleic acid of defined nucleotide sequence which codes for a deoxyribonuclease; for production of enough enzyme for clinical use; diagnosis; treatment of cystic fibrosis, lupus, chronic bronchitis, pneumonia, emphysema, and asthma |
| 07/24/2001 | US6265189 Expressing polypeptide in cell culture; insert gene into viral expression vector, transform cells, recover preferential polypeptide |
| 07/24/2001 | US6265188 Nucleotide sequence coding a enzymatic polypeptide; for use as a wound healing agent; for prevention of bacterial infection |
| 07/24/2001 | US6265184 Polynucleotides encoding chemokine receptor 88C |
| 07/24/2001 | US6265175 Incubating components comprising neuroblast and composition to be tested for ability to stimulate or inhibit proliferation or differentiation of the neuroblast to allow composition to bind to neuroblast, culturing, detecting effect |
| 07/24/2001 | US6265173 Methods of modulating the expression of genes using ultraspiracle receptor |
| 07/24/2001 | US6265150 Phage antibodies |
| 07/24/2001 | US6264954 Immunogenic peptide |
| 07/24/2001 | US6264953 Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception |
| 07/24/2001 | US6264950 Complex of protein and immunoglobulin |
| 07/24/2001 | US6264947 Genetic engineering; therapy for cancer, autoimmune diseases, reproduction, antiinflammatory agents |
| 07/24/2001 | CA2205006C Modified green fluorescent proteins |
| 07/24/2001 | CA2040810C Process for producing foreign proteins in streptomyces |
| 07/24/2001 | CA2024629C Xenopus laevis bone morphogenic protein, dna encoding same and use thereof |
| 07/19/2001 | WO2001051642A2 Dna modification proteins |
| 07/19/2001 | WO2001051636A2 Secreted proteins |
| 07/19/2001 | WO2001051635A2 Novel stra6 polypeptides |
| 07/19/2001 | WO2001051616A2 Techniques for growth and differentiation of human pluripotent stem cells |
| 07/19/2001 | WO2001051520A2 Nogo receptor-mediated blockade of axonal growth |
| 07/19/2001 | WO2001051515A2 Genes differentially expressed in breast cancer |
| 07/19/2001 | WO2001051510A2 G-csf conjugates |
| 07/19/2001 | WO2001051507A1 Novel peptide and screening method by using the same |
| 07/19/2001 | WO2001051068A1 Method and device for increasing and/or decreasing the concentration of immunomodulatory-active substances in substance mixtures |
| 07/19/2001 | WO2001014414A3 Human abc2 transporter and uses thereof |
| 07/19/2001 | WO2001005969A3 Electron transfer proteins |
| 07/19/2001 | WO2001000844A3 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 07/19/2001 | WO2000078922A3 Acid-inducible promoters for gene expression |
| 07/19/2001 | WO2000073324A3 Modulation of gene expression in gastrointestinal inflammation |
| 07/19/2001 | WO2000071716A3 Vascular endothelial growth factor dimers |
| 07/19/2001 | WO2000069891A3 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 07/19/2001 | WO2000055321B1 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 07/19/2001 | WO2000052146A3 Encryption of traits using split gene sequences |
| 07/19/2001 | US20010008936 Oligonucleotides having chiral phosphorus linkages |
| 07/19/2001 | US20010008764 Heparin binding protein |
| 07/19/2001 | US20010008634 Bactericides, fungicides, insecticides |
| 07/19/2001 | CA2406722A1 Dna modification proteins |
| 07/19/2001 | CA2397334A1 Secreted proteins |
| 07/19/2001 | CA2397207A1 Novel stra6 polypeptides |
| 07/19/2001 | CA2397199A1 Nogo receptor-mediated blockade of axonal growth |
| 07/19/2001 | CA2396889A1 Novel peptide and screening method by using the same |
| 07/18/2001 | EP1116793A1 Homeobox genes encoding proteins participating in differentiation |
| 07/18/2001 | EP1116792A1 New human growth differentiation factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 07/18/2001 | EP1116029A1 Apoptosis marker antibodies and methods of use |
| 07/18/2001 | EP1115879A1 Retroviral particles protected against complement mediated destruction |
| 07/18/2001 | EP1115878A1 Recombinant celo virus and celo virus dna |
| 07/18/2001 | EP1115876A2 Receptor based antagonists and methods of making and using |
| 07/18/2001 | EP1115875A1 Human complement c3-degrading polypeptide from streptococcus pneumoniae |
| 07/18/2001 | EP1115874A2 Alzheimer's disease secretase |
| 07/18/2001 | EP1115867A1 Human interleukin-b50. therapeutic uses |
| 07/18/2001 | EP1115865A2 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
| 07/18/2001 | EP1115864A2 Human chaperone proteins |
| 07/18/2001 | EP1115863A1 Ucp4 |
| 07/18/2001 | EP1115862A2 Cytokine receptor zalpha11 |
| 07/18/2001 | EP1115860A2 Membrane-associated organizational proteins |
| 07/18/2001 | EP1115852A1 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
| 07/18/2001 | EP1115847A1 Short peptides which selectively modulate the activity of protein kinases |
| 07/18/2001 | EP1115746A2 Antibodies to mammalian langerhans cell antigen and their uses |
| 07/18/2001 | EP1115735A1 31 human secreted proteins |
| 07/18/2001 | EP1115426A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer |
| 07/18/2001 | EP1115418A2 Aglyco products and methods of use |
| 07/18/2001 | EP0742830B1 Fusion proteins that include antibody and nonantibody portions |
| 07/18/2001 | EP0681588A4 Max-interacting proteins and related molecules and methods |
| 07/18/2001 | EP0667787B1 Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines |
| 07/18/2001 | EP0575555B1 Protein-induced morphogenesis |
| 07/18/2001 | CN1304454A Novel nucleic acids and polypeptides related to farnesyl-directed endopeptidase |
| 07/18/2001 | CN1304453A Vaccine-induced hepatitis B viral strain and uses thereof |
| 07/18/2001 | CN1304451A Fusion proteins of i(mycobacterium tuberuculosis) antigens and their uses |
| 07/18/2001 | CN1304450A Novel insulin analogs with enhanced zinc binding |
| 07/18/2001 | CN1304449A Novel angiotensin receptor, production and use thereof |
| 07/18/2001 | CN1303947A Method for producing human angiogenesis inhibine |
| 07/18/2001 | CN1303938A Novel polypeptide-human MATH37 and polynucleotide coding said polypeptide |